首页> 美国卫生研究院文献>Cell Division >Protein arginine methylation: an emerging regulator of the cell cycle
【2h】

Protein arginine methylation: an emerging regulator of the cell cycle

机译:蛋白质精氨酸甲基化:细胞周期的新兴调节剂

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Protein arginine methylation is a common post-translational modification where a methyl group is added onto arginine residues of a protein to alter detection by its binding partners or regulate its activity. It is known to be involved in many biological processes, such as regulation of signal transduction, transcription, facilitation of protein–protein interactions, RNA splicing and transport. The enzymes responsible for arginine methylation, protein arginine methyltransferases (PRMTs), have been shown to methylate or associate with important regulatory proteins of the cell cycle and DNA damage repair pathways, such as cyclin D1, p53, p21 and the retinoblastoma protein. Overexpression of PRMTs resulting in aberrant methylation patterns in cancers often correlates with poor recovery prognosis. This indicates that protein arginine methylation is also an important regulator of the cell cycle, and consequently a target for cancer regulation. The effect of protein arginine methylation on the cell cycle and how this emerging key player of cell cycle regulation may be used in therapeutic strategies for cancer are the focus of this review.
机译:蛋白质精氨酸甲基化是一种常见的翻译后修饰,其中甲基被添加到蛋白质的精氨酸残基上,以改变其结合伴侣的检测或调节其活性。众所周知,它涉及许多生物学过程,例如信号转导的调控,转录,促进蛋白质间相互作用,RNA剪接和转运。已显示负责精氨酸甲基化的酶,蛋白质精氨酸甲基转移酶(PRMT)可甲基化或与细胞周期和DNA损伤修复途径的重要调节蛋白(如细胞周期蛋白D1,p53,p21和成视网膜细胞瘤蛋白)结合。 PRMT的过表达导致癌症中甲基化模式异常,通常与不良的预后相关。这表明蛋白质精氨酸甲基化也是细胞周期的重要调节剂,因此是癌症调节的靶标。蛋白质精氨酸甲基化对细胞周期的影响以及这种新兴的细胞周期调控关键因素如何用于癌症的治疗策略是本综述的重点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号